113 related articles for article (PubMed ID: 8566054)
1. Tepoxalin blocks neutrophil migration into cutaneous inflammatory sites by inhibiting Mac-1 and E-selectin expression.
Zhou L; Pope BL; Chourmouzis E; Fung-Leung WP; Lau CY
Eur J Immunol; 1996 Jan; 26(1):120-9. PubMed ID: 8566054
[TBL] [Abstract][Full Text] [Related]
2. The NF-kappa B inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11b/CD18 and CD106.
Lee DH; Tam SS; Wang E; Taylor GR; Plante RK; Lau CY
Immunol Lett; 1996 Nov; 53(2-3):109-13. PubMed ID: 9024987
[TBL] [Abstract][Full Text] [Related]
3. Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase.
Kazmi SM; Plante RK; Visconti V; Taylor GR; Zhou L; Lau CY
J Cell Biochem; 1995 Feb; 57(2):299-310. PubMed ID: 7759567
[TBL] [Abstract][Full Text] [Related]
4. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.
Kirchner T; Aparicio B; Argentieri DC; Lau CY; Ritchie DM
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):417-23. PubMed ID: 9223651
[TBL] [Abstract][Full Text] [Related]
5. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
6. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.
Pierce JW; Read MA; Ding H; Luscinskas FW; Collins T
J Immunol; 1996 May; 156(10):3961-9. PubMed ID: 8621937
[TBL] [Abstract][Full Text] [Related]
7. ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism.
Chen L; Zhao Q; Wang XL; You R; Zhang YH; Ji H; Lai YS
Vascul Pharmacol; 2011; 55(5-6):135-42. PubMed ID: 21777697
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-modulating activity of tepoxalin, a new potential antirheumatic.
Ritchie DM; Argentieri DC; Aparicio BL; Plante RK; Lau CY; Barbone AG
Int J Immunopharmacol; 1995 Oct; 17(10):805-12. PubMed ID: 8707445
[TBL] [Abstract][Full Text] [Related]
9. Human cardiac fibroblasts express ICAM-1, E-selectin and CXC chemokines in response to proinflammatory cytokine stimulation.
Turner NA; Das A; O'Regan DJ; Ball SG; Porter KE
Int J Biochem Cell Biol; 2011 Oct; 43(10):1450-8. PubMed ID: 21718796
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil CD18-dependent arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow can be activated through L-selectin.
Gopalan PK; Smith CW; Lu H; Berg EL; McIntire LV; Simon SI
J Immunol; 1997 Jan; 158(1):367-75. PubMed ID: 8977212
[TBL] [Abstract][Full Text] [Related]
11. The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha.
Fiebich BL; Hofer TJ; Lieb K; Huell M; Butcher RD; Schumann G; Schulze-Osthoff K; Bauer J
Neuropharmacology; 1999 Sep; 38(9):1325-33. PubMed ID: 10471086
[TBL] [Abstract][Full Text] [Related]
12. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
13. The role of E- and P-selectin in neutrophil and monocyte migration in adjuvant-induced arthritis in the rat.
Walter UM; Issekutz AC
Eur J Immunol; 1997 Jun; 27(6):1498-505. PubMed ID: 9209503
[TBL] [Abstract][Full Text] [Related]
14. Tepoxalin inhibits inflammation and microvascular dysfunction induced by abdominal irradiation in rats.
Panés J; Mollà M; Casadevall M; Salas A; Sans M; Conill C; Anderson DC; Roselló-Catafau J; Granger DN; Piqué JM
Aliment Pharmacol Ther; 2000 Jun; 14(6):841-50. PubMed ID: 10848671
[TBL] [Abstract][Full Text] [Related]
15. Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes.
Markovic N; McCaig LA; Stephen J; Mizuguchi S; Veldhuizen RA; Lewis JF; Cepinskas G
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1066-76. PubMed ID: 19815624
[TBL] [Abstract][Full Text] [Related]
16. Dopamine attenuates the chemoattractant effect of interleukin-8: a novel role in the systemic inflammatory response syndrome.
Sookhai S; Wang JH; Winter D; Power C; Kirwan W; Redmond HP
Shock; 2000 Sep; 14(3):295-9. PubMed ID: 11028546
[TBL] [Abstract][Full Text] [Related]
17. Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection.
Fung-Leung WP; Pope BL; Chourmouzis E; Panakos JA; Lau CY
Transplantation; 1995 Aug; 60(4):362-8. PubMed ID: 7652766
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the CD11b/CD18 integrin, but not of the endothelial cell adhesion molecules ELAM-1 and ICAM-1 in tumor necrosis factor-alpha-induced neutrophil toxicity.
von Asmuth EJ; van der Linden CJ; Leeuwenberg JF; Buurman WA
J Immunol; 1991 Dec; 147(11):3869-75. PubMed ID: 1719092
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of methylthiouracil in vitro and in vivo.
Ku SK; Baek MC; Bae JS
Toxicol Appl Pharmacol; 2015 Nov; 288(3):374-86. PubMed ID: 26298005
[TBL] [Abstract][Full Text] [Related]
20. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism.
Salas A; Sans M; Soriano A; Reverter JC; Anderson DC; Piqué JM; Panés J
Gut; 2000 Jul; 47(1):88-96. PubMed ID: 10861269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
